Otis Worldwide reported Q2 earnings on July 22, and the market's reaction will define how the contradictory signals that built ahead of the print — aggressive call buying, quietly growing short interest — resolve.
The options picture shifted sharply into earnings. The put/call ratio collapsed to 0.57 on Tuesday, sitting nearly 1.6 standard deviations below its 20-day average of 0.87. That is the most call-heavy reading in weeks. A day earlier, on July 20, the PCR had spiked to 1.18 — one of the more defensive readings of the month. The whipsaw between those two sessions captures the underlying uncertainty: traders were hedging hard, then rotating aggressively into upside exposure right before the number dropped. The PCR has since settled at its current level, but the direction of travel from here depends entirely on whether the print delivered the H2 acceleration management had been signalling.
Short interest tells a different story from the call flow. Bears have been building steadily — SI has climbed 34% over the past month to 4.2% of free float, with the bulk of that accumulation concentrated between late June and mid-July. That monthly build is one of the more sustained moves in the stock's recent history. The cost to borrow has also jumped, more than doubling over the past week to 0.71% — still low in absolute terms, but the direction is notable given how flat it had been through June. Availability remains extremely loose at over 3,500%, meaning there is no squeeze pressure and shorts face no friction adding to positions. The borrow market is signalling that this is a conviction-driven accumulation, not a forced unwind.
The Street was already cautious before the print. The most recent analyst moves cluster around April: RBC trimmed its target from $110 to $105 while keeping Outperform, Barclays lowered to $77 maintaining Underweight, and Wolfe Research downgraded to Peer Perform. The consensus mean target of $93.42 implies roughly 30% upside from Tuesday's close of $71.95 — a gap that has widened as the stock fell, not because targets rose. The bear case centres on the fourth consecutive guidance cut and a Q2 organic sales decline of 2%. Bulls point to modernisation order intake up 22% year-on-year and backlog growth of 16%. The EV/EBITDA multiple has compressed modestly to 12.6x over the past month, while the PE has ticked down to 16x — valuation becoming incrementally less demanding, though not yet cheap enough to silence the sceptics.
Among industrial machinery peers, the divergence on Tuesday was stark. ESAB rose 3.7% and OSK gained 3.1%, while OTIS fell 2.1% — underperforming the group sharply on a day when broader industrials held up. For the week, IR added 2.4% and NDSN gained 1.1%, while OTIS lost 0.8%. The relative softness into the print suggests the market was pricing in downside risk, not optimism.
What to watch now is whether the Q2 result — out today — gives bulls any concrete evidence that the H2 backlog conversion story is on track, or whether a fifth consecutive guidance revision confirms the bears' thesis and accelerates the short position that has been quietly building all month.
See the live data behind this article on ORTEX.
Open OTIS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
